A woman wearing a facemask (pictured) during the Covid-19 pandemic, an event which has hampered the progress of medical research.
Nicola Perrin, CEO of the Association of Medical Research Charities said: “The financial year of 2020/21 was predictably difficult for the sector. The pandemic’s impact was as we projected, severe, with a shortfall of £260 million in research spend mainly caused by the hit to fundraising income.
“This has forced our charities to re-forecast their research spend over the next few years and many have had to make difficult decisions. Over a third of our members have had to cancel or cut funding for early-career researchers and research into new treatments.
“We’re seeing encouraging signs of resilience and recovery, with more charities increasing their research spend and over a third saying their spend had not been affected or had already recovered. Unfortunately, though, for many there is still a long way to go.
“Most are still struggling with the impact of Covid-19 and anticipate more challenges with the rise in cost-of-living and the loss of access to EU research funding programmes, talent and opportunities for international collaborations. Public donations have also been directed towards alternative causes with the proportion of people giving to medical research dropping from 25% in 2019 to 21% in 2021.
“AMRC will continue to support our charities in growing their research investment and strengthening the UK’s extraordinary and collaborative system, to deliver ground-breaking treatments and innovations that benefit us all.”
Read more about DRWF and AMRC
Support DRWF by making a donation here
Find out more about DRWF-funded research here
Find out more about DRWF fundraising here
To receive the charity’s latest bulletins as they become available, please sign up here
Read DRWF diabetes information leaflets here
Join the Diabetes Wellness Network here
I would like to make a regular donation of
I would like to make a single donation of